Guidemark Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Guidemark Health, Inc. - overview
Established
2014
Location
Parsippany, NJ, US
Primary Industry
Marketing/Advertising
About
Guidemark Health, Inc. provides strategic insights and solutions for the life sciences sector, focusing on data-driven decision-making to optimize product development and market access. Founded in 2014 and headquartered in Parsippany, US, Guidemark Health, Inc. specializes in strategic consulting for the life sciences industry.
The company has undergone significant changes, particularly in November 2021, when it was acquired by Pharma Value Demonstration Bidco Limited from High Road Capital Partners and SR Capital Advisors. The acquisition aimed to enhance offerings in medical affairs and commercial strategies. The CEO, Michael Parisi, leads the company, which has successfully closed 2 deals to date, with the most recent deal occurring on November 2, 2021. Guidemark Health, Inc.
offers services that include Insight Strategy Consulting, Real World Evidence, and Value, Access & Outcomes solutions tailored for the life sciences sector. These services are designed to support product development, market access, and commercialization strategies by leveraging real-world data and insights. Their clientele includes nearly all top pharmaceutical companies and over 100 biotech firms globally, with projects active across North America, the United Kingdom, European Union, and Asia, facilitating deeper engagement within complex healthcare environments. Guidemark Health, Inc.
generates revenue through partnership agreements and consulting contracts with life science companies. This involves B2B relationships where clients seek customized consulting services or access to proprietary market insights. Their pricing structure is contingent on project scope and complexity, reflecting high-stakes engagements that are critical for effective market access strategies. The acquisition by Pharma Value Demonstration Bidco Limited in November 2021 is expected to bolster Guidemark Health's capabilities in the medical affairs and commercial sectors.
The strategic direction focuses on expanding their service offerings and further penetrating existing markets. Plans may include designing new products to enhance their portfolio and targeting an expansion into additional geographic markets as they develop their strategies for future growth.
Current Investors
Arsenal Capital Partners, Value Demonstration Company
Primary Industry
Marketing/Advertising
Sub Industries
Consulting Services, Public Relations & Communications, Market Research & Consulting, eMarketing/Digital Marketing, Education & Training Services, Healthcare
Website
www.guidemarkhealth.com
Verticals
AdTech
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Guidemark Health, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Guidemark Health, Inc. | - | ||||||||
| Buyout | Completed | Guidemark Health, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.